Adalimumab BS Subcutaneous Injection 40mg Pen 0.8mL “Daiichi Sankyo” contains adalimumab (genetical recombination) [Adalimumab successor 2] and is manufactured by Daiichi Sankyo. This injectable drug, with YJ code 3999459G3021, is supplied as 40mg in 0.8mL per kit.
Adalimumab BS Subcutaneous Injection 40mg Pen 0.8mL “Daiichi Sankyo”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →